Senate ‘Innovation’ Bill Being Narrowed With Year-End Committee Passage In Mind
Counterpart to House Cures bill likely to focus on ‘big buckets’ of issues, including new approval pathway for antibiotics, reforms at NIH and biomarker development.
Counterpart to House Cures bill likely to focus on ‘big buckets’ of issues, including new approval pathway for antibiotics, reforms at NIH and biomarker development.